California
CNS medication trials in California
168 CNS medication studies are recruiting participants at sites in 83 cities across California as of November 17, 2026, according to ClinicalTrials.gov.
- No cost to ask
- Taking part is voluntary
- Studies are independently reviewed
Browse California by city
Cities with the most studies recruiting right now.
Los Angeles
37 studies recruiting.
Orange
35 studies recruiting.
Anaheim
25 studies recruiting.
San Diego
25 studies recruiting.
Walnut Creek
24 studies recruiting.
Every California city with a recruiting study
By research area: Depression (44), Schizophrenia (36), Parkinson's Disease (25), Multiple Sclerosis (19), Migraine (18), Epilepsy (13), Bipolar Disorder (7), ADHD (6).
Los Angeles (37), Orange (35), Anaheim (25), San Diego (25), Walnut Creek (24), Chino (20), Garden Grove (20), San Francisco (20), Oceanside (19), Long Beach (18), Irvine (16), Bellflower (14), Culver City (14), La Jolla (14), Riverside (14), Palo Alto (13), Redlands (13), San Jose (13), Glendale (11), Torrance (11), Lemon Grove (10), Sacramento (10), Fresno (9), Montclair (8), Pico Rivera (8), Fullerton (7), Los Alamitos (7), Sherman Oaks (7), Stanford (7), West Covina (7), Canoga Park (5), Pomona (5), Cerritos (4), Colton (4), Fountain Valley (4), La Habra (4), West Hills (4), West Hollywood (4), Costa Mesa (3), Duarte (3), Encino (3), Imperial (3), Lafayette (3), Newport Beach (3), Pasadena (3), Temecula (3), Burbank (2), Mather (2), Mission Viejo (2), Moorpark (2), Murrieta (2), Oakland (2), Santa Monica (2), Spring Valley (2), Upland (2), Valley Village (2), Aliso Viejo (1), Bakersfield (1), Beverly Hills (1), Buena Park (1), Carlsbad (1), Chula Vista (1), Clovis (1), Hawthorne (1), La Palma (1), Ladera Ranch (1), Lancaster (1), Loma Linda (1), Lynwood (1), Mission Hills (1), Modesto (1), Mountain View (1), Palm Springs (1), Palmdale (1), Rancho Cucamonga (1), Redding (1), San Juan Capistrano (1), Santa Ana (1), Sherman (1), Solvang (1), Van Nuys (1), Whittier (1), Winnetka (1).
The number after each city is how many studies have a recruiting site there. A study with sites in several cities is counted in each one.
Depression: recently updated in California
Basic details from each study's public record (the 12 most recently updated of 168). Select a study to read the full record on ClinicalTrials.gov, including how to contact its team.
Double-blind, Placebo-controlled Study in Adults With Major Depressive Disorder
- Phase 2
- Ages 18 to 70
- All sexes
- Sponsor
- Supernus Pharmaceuticals, Inc.
- Recruiting in
- Chino · Encino · Garden Grove · and 5 more U.S. locations
- Registry record
- NCT07226661 · updated
A Study of a Deuterated Psilocin Analog (CYB003) in Humans With Major Depressive Disorder
- Phase 3
- Ages 18 to 85
- All sexes
- Sponsor
- Cybin IRL Limited
- Recruiting in
- Glendale · Los Angeles · Orange · and 2 more U.S. locations
- Registry record
- NCT06793397 · updated
Source: ClinicalTrials.gov. Data processed . See every depression study recruiting in California on ClinicalTrials.gov.
Parkinson's disease: recently updated in California
A Study of Pembrolizumab (MK-3475) With or Without Intismeran Autogene (V940) in Participants With Non-small Cell Lung Cancer (V940-009/INTerpath-009)
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Merck Sharp & Dohme LLC
- Recruiting in
- Fullerton · Long Beach · Los Angeles · and 1 more U.S. location
- Registry record
- NCT06623422 · updated
A Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) as Monotherapy and in Combination With Pembrolizumab (MK-3475) in Participants With Triple-Negative Breast Cancer (MK-2870-011/TroFuse-011)
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Merck Sharp & Dohme LLC
- Recruiting in
- Duarte · Irvine · Los Angeles · and 1 more U.S. location
- Registry record
- NCT06841354 · updated
A Study to Compare Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) Versus Pembrolizumab Alone as Treatment in Participants With Mismatch Repair Proficient Endometrial Cancer (MK-2870-033/TroFuse-033/GOG-3119/ENGOT-en29)
- Phase 3
- Ages 18 and older
- Female participants
- Sponsor
- Merck Sharp & Dohme LLC
- Recruiting in
- Irvine · Orange · Solvang · and 1 more U.S. location
- Registry record
- NCT06952504 · updated
A Clinical Study of Sacituzumab Tirumotecan (Sac-TMT, MK-2870) in People With Breast Cancer (MK-2870-032)
- Phase 3
- Ages 18 and older
- All sexes
- Sponsor
- Merck Sharp & Dohme LLC
- Recruiting in
- Burbank · Clovis · Fullerton · and 4 more U.S. locations
- Registry record
- NCT06966700 · updated
A Clinical Study of Sacituzumab Tirumotecan (MK-2870) in Combination With Pembrolizumab (MK-3475) as First-line Maintenance Treatment of Cervical Cancer (MK-2870-036/TroFuse-036/GOG-3123/ENGOT-cx22)
- Phase 3
- Ages 18 and older
- Female participants
- Sponsor
- Merck Sharp & Dohme LLC
- Recruiting in
- Irvine · La Jolla · Orange
- Registry record
- NCT07216703 · updated
DESTINY-Endometrial01: A Phase III Study of Trastuzumab Deruxtecan Plus Rilvegostomig or Pembrolizumab as First-Line Treatment of HER2-Expressing (IHC 3+/2+), Mismatch Repair Proficient (pMMR) Endometrial Cancer
- Phase 3
- Ages 18 and older
- Female participants
- Sponsor
- AstraZeneca
- Recruiting in
- Duarte · Irvine · La Jolla
- Registry record
- NCT06989112 · updated
Substudy 06C: A Study of Investigational Agents With Pembrolizumab (MK-3475) and Chemotherapy in Participants With First-Line Locally Advanced Unresectable/Metastatic Gastroesophageal Adenocarcinoma (MK-3475-06C/KEYMAKER-U06)
- Phase 1/2
- Ages 18 and older
- All sexes
- Sponsor
- Merck Sharp & Dohme LLC
- Recruiting in
- Los Angeles
- Registry record
- NCT06469944 · updated
Source: ClinicalTrials.gov. Data processed . See every Parkinson's disease study recruiting in California on ClinicalTrials.gov.
Multiple sclerosis (MS): recently updated in California
Study of KITE-363 in Participants With Autoimmune Neurologic Diseases That Did Not Respond to Usual Treatment
- Phase 1
- Ages 18 to 75
- All sexes
- Sponsor
- Kite, A Gilead Company
- Recruiting in
- Newport Beach · Palo Alto
- Registry record
- NCT07304154 · updated
Source: ClinicalTrials.gov. Data processed . See every multiple sclerosis study recruiting in California on ClinicalTrials.gov.
Epilepsy: recently updated in California
Study Evaluating the Efficacy and Safety of RAP-219 in Adult Participants With Focal Seizures FOCUS-1
- Phase 3
- Ages 18 to 75
- All sexes
- Sponsor
- Rapport Therapeutics Inc.
- Recruiting in
- Palmdale · San Francisco
- Registry record
- NCT07563881 · updated
Source: ClinicalTrials.gov. Data processed . See every epilepsy study recruiting in California on ClinicalTrials.gov.
Migraine: recently updated in California
Comparative Effectiveness of Migraine Preventive Medications: The APT Comparison Study
- Phase 4
- Ages 18 to 70
- All sexes
- Sponsor
- Mayo Clinic
- Recruiting in
- Los Angeles · Palm Springs · Pomona
- Registry record
- NCT06972056 · updated
Source: ClinicalTrials.gov. Data processed . See every migraine study recruiting in California on ClinicalTrials.gov.
Ask about studies in California
Tell us what you are looking for and a coordinator will contact you to talk through your options. Asking does not commit you to anything.
Before you contact a study
How taking part works
From your first question to your decision: what happens and who you talk to along the way.
Questions to ask a study team
What to ask about time, risks and your rights before you agree to anything.
Eligibility and screening
How a study team works out whether a study is suitable for you.
About these listings
These listings come from ClinicalTrials.gov, the study registry run by the U.S. National Library of Medicine. The data were processed on November 17, 2026. We show part of each public record (its title, phase, sponsor, basic eligibility and sites in this area) exactly as registered, and we group studies by place. Nothing in a record is reworded. This site lists only studies that test a medication, as each study is coded in the registry.
CNS Medication Trials does not run these studies and is not affiliated with their sponsors. A listing is not a recommendation, and only a study's own team can tell you whether you may be eligible. Follow the link on any study to read its full record and contact that team directly, or ask us and a coordinator will help you understand your options. How we source and check what we publish.
Sources and further reading
- ClinicalTrials.gov study registry — ClinicalTrials.gov (National Library of Medicine)
- Terms and Conditions for use of ClinicalTrials.gov data — ClinicalTrials.gov (National Library of Medicine)
- Questions to Ask About Volunteering for a Research Study — HHS Office for Human Research Protections